Article Text
Abstract
Objectives To determine and describe the prevalence and pattern of dyslipidaemia and its associated risk factors among an adult Emirati population.
Design Population-based, cross-sectional study.
Setting Adults living in the Northern Emirates.
Participants 824 adult participants (51.8% men, 48.2% women, mean age 42.8±13.4 years old).
Primary outcome measures Fasting blood samples were collected, blood pressure and waist circumference were measured.
Results The overall dyslipidaemia prevalence was 72.5%, with 42.8% of the participants showing high total cholesterol (TC) level, 29% showing high triglyceride (TG) level, 42.5% showing low high-density lipoprotein cholesterol (HDL-C) level, 38.6% showing high low-density lipoprotein cholesterol (LDL-C) level and 72.3% showing high cholesterol ratio. The regression models showed that gender was a significant predictor of a high TG level, low LDL-C level and high cholesterol ratio. Middle-aged individuals (30–59 years old) had a significantly higher risk of having high TC, TG and LDL-C levels than young (<30 years old) and elderly (≥60 years old) individuals. Diabetes mellitus was a significant predictor of low TC, high TG and low HDL-C levels, while central obesity was a significant predictor of a high TG level, low HDL-C level and high cholesterol ratio. Smoking was a significant predictor of a high TG level only in men.
Conclusions The prevalence of dyslipidaemia was considerably high among the local adult Emiratis. The identified dyslipidaemia predictors were gender, age, smoking, central obesity and diabetes. Further studies are recommended to assess other important risk factors and aggressive preventive measures in the United Arab Emirates.
- epidemiology
- lipid disorders
- ischaemic heart disease
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Footnotes
Contributors NS conceived and designed the study. IM conducted the statistical analysis and interpretation of data, and drafted the manuscript. Both authors critically revised the manuscript and gave final approval of the present version to be submitted. NS is the guarantor of this research.
Funding This work was supported by the Ministry of Health and Prevention, University of Sharjah and Sanofi (grant number 120301).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The Ministry of Health and Prevention Research Ethics Committee approved this study (MOHP/DXB/RE-SUBC/NO-12/2016). A signed informed consent from all participants was obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request.